Диссертация (1174280), страница 19
Текст из файла (страница 19)
Чердынцева. //Бюллетень СО РАМН – 2004 - № 112 (№2) - C. 41–47.12923. Щербакова, Н.И. Миастенический синдром Ламберта—Итона:особенности иммунного ответа/ Н.И. Щербакова, В.Б. Ланцова; под общейред. Е.И. Гусев, Н.Н. Яхно, А.Г. Санадзе – 2007 – С. 166—171.24. Abenroth, D. C. Lambert–Eaton myasthenic syndrome: epidemiology andtherapeutic response in the national veterans affairs population / D.C.
Abenroth,A.G. Smith, J.E. Greenlee et al.//Muscle & nerve. – 2017. – Т. 56. – №. 3. – С.421-426.25. Abicht, A. What's in the serum of seronegative MG and LEMS?: MuSK et al /A. Abicht, H. Lochmüller.//Neurology. – 2002. – Т. 59. – №. 11. – С. 1672.26. Abbott, C. A. Prevalence and characteristics of painful diabetic neuropathy in alarge community-based diabetic population in the UK / C.A. Abbott, R.A. Malik,E.R. van Ross et al.//Diabetes care. – 2011. – Т. 34. – №. 10. – С. 2220-2224.27.
Anderson, H. J. Bronchial neoplasm with myasthenia: prolonged apnoea afteradministration of succinylcholine / H.J. Anderson, H.C. Churchill-Davidson, A.T.Richardson.//The Lancet. – 1953. – Т. 262. – №. 6799. – С. 1291-1293.28. Barton, J. S. Ocular aspects of myasthenia gravis / J.S. Barton, M.Fouladvand.//Seminars in neurology.
– Copyright© 2000 by Thieme MedicalPublishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA., 2000. – Т. 20.– №. 01. – С. 0007-0020.29. Baslo, M. B. Decrement pattern in Lambert–Eaton myasthenic syndrome isdifferent from myasthenia gravis / M.B. Baslo, F.
Deymeer, P. Serdaroglu etal.//Neuromuscular Disorders. – 2006. – Т. 16. – №. 7. – С. 454-458.30. Nagel, A. Congenital End‐plate Acetylcholine Receptor Deficiency and ShortChannel Open Time a / A. Nagel, A.G. Engel, T.J. Wallset et al.//Annals of theNew York Academy of Sciences. – 1993. – Т. 681. – №. 1. – С. 509-514.31. Benatar, M. Presynaptic neuronal antigens expressed by a small cell lungcarcinoma cell line / M. Benatar, F. Blaes, I. Johnston et al.//Journal ofneuroimmunology. – 2001. – Т.
113. – №. 1. – С. 153-162.32. Betz, W. J. Depression of transmitter release at the neuromuscular junction ofthe frog /W.J. Betz.//The Journal of physiology. – 1970. – Т. 206. – №. 3. – С.629-644.33. Brannagan III, T. H. Current issues in peripheral neuropathy / T.H. BrannaganIII.//Journal of the Peripheral Nervous System.
– 2012. – Т. 17. – С. 1-3.13034. Briggs, S. E. The association between Lambert–Eaton myasthenic syndromeand small cell lung carcinoma / S.E. Briggs, P. Gozzard, D.C. Talbot.//ImmunoTargets and therapy. – 2013. – Т. 2. – С. 31..35. Brown, W.F. The physiological and technical basis of electromyography / W.F.Brown. – Butterworth-Heinemann, 2013.36. Burns, T. M. Oculobulbar involvement is typical with Lambert–Eatonmyasthenic syndrome / T.M. Burns, J.A. Russell, D.H. LaChance et al.//Annals ofNeurology: Official Journal of the American Neurological Association and theChild Neurology Society. – 2003.
– Т. 53. – №. 2. – С. 270-273.37. Catterall, W.A. Voltage-gated calcium channels / W.A. Catterall.// Cold SpringHarbor Perspectives in Biology. – 2011. – № 8 (3). – C. 1–23.38. Charlton, M. P. Role of presynaptic calcium ions and channels in synapticfacilitation and depression at the squid giant synapse / M.P. Charlton, S.J. Smith,R.S. Zucker //The Journal of Physiology. – 1982. – Т.
323. – №. 1. – С. 173-193.39. van Coevorden-Hameete, M. H. Molecular and cellular mechanisms underlyinganti-neuronal antibody mediated disorders of the central nervous system / M.H.van Coevorden-Hameete, E. de Graaff, M.J. Titulaer et al.//Autoimmunity reviews.– 2014. – Т. 13. – №. 3. – С. 299-312.40. Chiou-Tan, F. Y. Practice parameter for repetitive nerve stimulation and singlefiber EMG evaluation of adults with suspected myasthenia gravis or LambertEaton myasthenic syndrome: summary statement / F.Y. Chiou-Tan, R.W.
Tim,J.M. Gilchrist et al.//Muscle and Nerve. – 2001. – Т. 24. – №. 9. – С. 1236-1238.41. Cull‐Candy, S. G. On the release of transmitter at normal, myasthenia gravisand myasthenic syndrome affected human end‐plates / S.G. Cull‐Candy, R. Miledi,A. Trautmann, O.D. Uchitel.//The Journal of physiology. – 1980. – Т. 299.
– №. 1.– С. 621-638.42. Davila, H. M. Molecular and functional diversity of voltage‐gated calciumchannels / H.M. Davila.//Annals of the New York Academy of Sciences. – 1999. –Т. 868. – №. 1. – С. 102-117.43. Desmedt, J. E. The neuromuscular disorder in myasthenia gravis / J.E.Desmedt.//New Concepts of the Motor Unit, Neuromuscular Disorders,Electromyographic Kinesiology. – Karger Publishers, 1973. – Т. 1. – С.
305-342.13144. Desmedt, J. E. Neuromuscular defect in myasthenia gravis.Electrophysiological and histopathological evidence / J.E. Desmedt. //Myastheniagravis. – Thomas Springfield, Ill, 1961. – С. 150-178.45. Desmedt, J. E. Diagnosis of myasthenia gravis by nerve stimulation / J.E.Desmedt, S. Borenstein.//Annals of the New York Academy of Sciences. – 1976.
–Т. 274. – №. 1. – С. 174-188.46. Didelot, A. Paraneoplastic disorders of the central and peripheral nervoussystems / A. Didelot, J. Honnorat. //Handbook of clinical neurology. – Elsevier,2014. – Т. 121. – С. 1159-1179.47. Eaton, L. M. Electromyography and electric stimulation of nerves in diseasesof motor unit: observations on myasthenic syndrome associated with malignanttumors / L.M. Eaton, E.H. Lambert.//Journal of the American Medical Association.– 1957. – Т.
163. – №. 13. – С. 1117-1124.48. Elmqvist, D. Presynaptic action of hemicholinium at the neuromuscularjunction / D. Elmqvist, D.M. Quastel.//The Journal of physiology. – 1965. – Т.177. – №. 3. – С. 463-482.49. Elrington, G. M. Neurological paraneoplastic syndromes in patients with smallcell lung cancer. A prospective survey of 150 patients / G.M. Elrington, N.M.Murray, S.G. Spiro et al.//Journal of Neurology, Neurosurgery & Psychiatry.
–1991. – Т. 54. – №. 9. – С. 764-767.50. Engel, A. G. Myasthenia gravis and myasthenic disorders /A.G. Engel. – OUPUSA, 2012. – Т. 81.51. Engel, W. K. Brief, small, abundant motor‐unit action potentials: A furthercritique of electromyographic interpretation /W.K. Engel.//Neurology. – 1975. – Т.25. – №. 2.
– С. 173-17352. Evoli, A. Italian recommendations for Lambert–Eaton myasthenic syndrome(LEMS) management / A. Evoli, R. Liguori, A. Romani et al.//NeurologicalSciences. – 2014. – Т. 35. – №. 4. – С. 515-520.53. El Far, O. Antigens associated with N‐and L‐type calcium channels inLambert‐Eaton myasthenic syndrome / O. El Far, B. Marquèze, C. Leveque etal.//Journal of neurochemistry. – 1995. – Т. 64. – №.
4. – С. 1696-1702.54. Fernandez-Torron, R. Isolated dysphagia due to paraneoplastic myasthenicsyndrome with anti-P/Q-type voltage-gated calcium-channel and anti-acetylcholine132receptor antibodies / R. Fernandez-Torron, J. Arcocha, J.M. López-Picazo et al.//Neuromuscular Disorders. – 2011. – Т. 21. – №. 2. – С. 126-128.55. Fong, C. S. Recent advance in immunological tests in paraneoplasticneurological syndrome / C.S.
Fong.//Acta Neurol Taiwan. – 2005. – Т. 14. – №. 1.– С. 28-35.56. Fukuda, M. Role of the conserved WHXL motif in the C terminus ofsynaptotagmin in synaptic vesicle docking / M. Fukuda, J.E. Moreira, V. Liu etal.//Proceedings of the National Academy of Sciences. – 2000. – Т. 97. – №. 26. –С. 14715-14719.57. Fukunaga, H. Passive transfer of Lambert-Eaton myasthenic syndrome withIgG from man to mouse depletes the presynaptic membrane active zones / H.Fukunaga, A.G.
Engel, B. Lang et al.//Proceedings of the National Academy ofSciences. – 1983. – Т. 80. – №. 24. – С. 7636-7640.58. Gable, K. L. Presynaptic Disorders: Lambert-Eaton Myasthenic Syndrome andBotulism / K.J. Gable, J.M. Massey.//Seminars in neurology. – Thieme MedicalPublishers, 2015. – Т. 35. – №. 04. – С.
340-346.59. Galassi, G. Lambert-Eaton myasthenic syndrome associated with intravascularuterine leiomyoma / G. Galassi, A. Ariatti, V. Agnoletto et al.//European Journal ofObstetrics and Gynecology and Reproductive Biology. – 2011. – Т. 159. – №. 1. –С. 230-231.60. Galton, C. Lambert-Eaton myasthenic syndrome and non-pulmonary small cellcarcinoma / C. Galton, D. Thomson, R. Boyle.//Journal of Neurology,Neurosurgery & Psychiatry. – 1998. – Т.
64. – №. 6. – С. 819-820.61. Gilhus, N. E. Lambert-eaton myasthenic syndrome; pathogenesis, diagnosis,and therapy / N.E. Gilhus.//Autoimmune diseases. – 2011. – Т. 2011.62. Govindan, R. Changing epidemiology of small-cell lung cancer in the UnitedStates over the last 30 years: analysis of the surveillance, epidemiologic, and endresults database / R. Govindan, N. Page, D.
Morgensztern et al.//Journal of clinicaloncology. – 2006. – Т. 24. – №. 28. – С. 4539-4544.63. Gutmann, L. Trends in the association of Lambert‐Eaton myasthenic syndromewith carcinoma / L. Gutmann, L.H. Phillips, L. Gutmann.//Neurology. – 1992. – Т.42. – №. 4. – С. 848-848.13364. Gutmann, L. Lambert–Eaton myasthenic syndrome with prominentpostexercise exhaustion / L. Gutmann, D. Weidman, A. Gutierrez.//Muscle &Nerve: Official Journal of the American Association of ElectrodiagnosticMedicine.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
